Scope International
Private Company
Funding information not available
Overview
Scope International is a well-established, privately-held German CRO with a 25-year track record, operating 11 offices across Europe and a global partner network. It offers end-to-end clinical development services, emphasizing flexibility, cost efficiency, and rapid timelines, which it contrasts favorably against larger, more rigid CROs. The company has developed its own proprietary technology platform to enhance service delivery and maintains strong therapeutic expertise across areas like pain, neurology, infectious diseases, and ATMPs. Its business model is purely service-based, generating revenue from pharmaceutical and biotech clients.
Technology Platform
Proprietary, modular platform including AI, CTMS, eTMF, EDC/ePRO/RTMS, Automated Safety Reporting, and eConsent capabilities. Built for flexibility and seamless integration.
Opportunities
Risk Factors
Competitive Landscape
Competes against large, global full-service CROs (like IQVIA, PPD, ICON) and other regional European CROs. Differentiates through its emphasis on flexibility, responsiveness, and a client-service culture, positioning itself as an agile alternative to larger, sometimes rigid, competitors.